loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 210660 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 CYSTEINE HYDROCHLORIDE (2)

filter

01 EXELA PHARMA (2)

filter

01 SOLUTION;INTRAVENOUS (2)

filter

01 2500MG/50ML (50MG/ML) (1)

02 500MG/10ML (50MG/ML) (1)

filter

01 USA (2)

URL Supplier Web Content
SOLUTION;INTRAVENOUS
500MG/10ML (50MG/ML)
ELCYS
USA
210660
2019-04-16
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION;INTRAVENOUS
2500MG/50ML (50MG/ML)
ELCYS
USA
210660
2023-12-04
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 210660

Looking for CTD TGA MCC DOSSIER APPLICATION 210660 2

19

Exela Pharma Sciences, LLC., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is CYSTEINE HYDROCHLORIDE, with a corresponding application number 210660 and regulatory information .

proudly manufactured in the

approval since 2019-04-16

Exela Pharma Sciences, LLC.'s ELCYS SOLUTION;INTRAVENOUS, medication with 500MG/10ML (50MG/ML) of CYSTEINE HYDROCHLORIDE.

18

Exela Pharma Sciences, LLC., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is CYSTEINE HYDROCHLORIDE, with a corresponding application number 210660 and regulatory information .

proudly manufactured in the

approval since 2023-12-04

Exela Pharma Sciences, LLC.'s ELCYS SOLUTION;INTRAVENOUS, medication with 2500MG/50ML (50MG/ML) of CYSTEINE HYDROCHLORIDE.

Post Enquiry
POST ENQUIRY